site:www.genengnews.com - 搜索图片

1380×844
www.genengnews.com
CAR-T Meets CAR-E, an Enhancer Platform to Prevent Cancer Relapse
2560×1707
www.genengnews.com
Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo ...
1478×933
www.genengnews.com
Amgen to Acquire Horizon for $27.8B, Expanding Rare Disease Pipeline
1966×1440
www.genengnews.com
Five Startups Enliven the Gene Therapy Scene in Asia

2560×1707
www.genengnews.com
Will Manufacturing Be the Stumbling Block for T-Cell Thera…
1536×1010
www.genengnews.com
Will Manufacturing Be the Stumbling Block for T-Cell Therap…
1600×1067
www.genengnews.com
Cellares Unveils Clinically-Compliant Cell Therapy Manufact…
1920×1080
www.genengnews.com
Come Together: Bridge RNAs Close the Gap to Genome Design

1768×1242
www.genengnews.com
FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell …
2048×920
www.genengnews.com
Uncovering Proteomic Patterns One Cell at a Time
2048×1849
www.genengnews.com
CRISPR Technology Turns 10, Rises to New Challenges
1250×1460
www.genengnews.com
REGENXBIO and Abbvie Advance …

2178×1376
www.genengnews.com
CRISPR-Cas9 Alternatives: Cutting through the Boundaries of Gene Editing

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果